Genoil (GNOLF) Revenue (2020 - 2025)
Historic Revenue for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to $8114.0.
- Genoil's Revenue rose 1576.54% to $8114.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$31048.0, marking a year-over-year increase of 9762.36%. This contributed to the annual value of $337848.0 for FY2019, which is 1200.0% up from last year.
- Genoil's Revenue amounted to $8114.0 in Q3 2025, which was up 1576.54% from $7792.0 recorded in Q2 2025.
- Over the past 5 years, Genoil's Revenue peaked at $328009.0 during Q2 2023, and registered a low of -$2.6 million during Q4 2022.
- Its 5-year average for Revenue is -$198001.8, with a median of $7792.0 in 2025.
- Its Revenue has fluctuated over the past 5 years, first surged by 20045.75% in 2021, then crashed by 9855.94% in 2023.
- Over the past 5 years, Genoil's Revenue (Quarter) stood at -$2.1 million in 2021, then fell by 25.79% to -$2.6 million in 2022, then surged by 48.66% to -$1.3 million in 2023, then skyrocketed by 95.9% to -$54440.0 in 2024, then soared by 114.9% to $8114.0 in 2025.
- Its last three reported values are $8114.0 in Q3 2025, $7792.0 for Q2 2025, and $7486.0 during Q1 2025.